Publications by authors named "D Plicner"
Article Synopsis
- * A study of 151 patients showed that the average knowledge score about VTE was only 62.5%, with those having diabetes or a family history of VTE scoring lower.
- * Poor knowledge was linked to higher instances of major bleeding and therapy discontinuation, but not to the recurrence of VTE, indicating that better patient education may improve safety and adherence to anticoagulant therapy.
Article Synopsis
- * Extracorporeal life support (ECLS) rewarming is the recommended first-line treatment for these patients, focusing on quickly restoring body temperature and ensuring proper organ blood flow.
- * Veno-arterial extracorporeal membrane oxygenation (ECMO) is a preferred method of ECLS, known for its efficiency but requires skilled medical staff due to its invasive nature and associated risks.
Introduction: Minimally invasive and hybrid procedures for patients with aortic valve pathology and coronary artery disease are innovative solutions.
Aim: To report the results of hybrid aortic valve replacement through right anterior minithoracotomy (RT-AVR)/percutaneous coronary intervention (PCI) and conventional aortic valve replacement (AVR)/coronary artery bypass grafting (CABG) surgery for patients with aortic valve and coronary artery disease.
Material And Methods: Analysis of prospectively gathered data of 187 patients - 86 hybrid and 101 conventional procedures.
Background: Morbidity and mortality following Fontan (FO) surgery are primarily thromboembolic in nature. However, follow-up data regarding thromboembolic complications (TECs) in adult patients after FO procedure are inconsistent. In this multicenter study, we investigated the incidence of TECs in FO patients.
View Article and Find Full Text PDFIntroduction: Rheumatoid arthritis (RA) is a risk factor (RF) for cardiovascular (CV) disease, a leading cause of mortality in RA patients.
Material And Methods: Consecutive records of RA patients with high disease activity screened upon biologic therapy initiation were reviewed between January 2001 and 2018. Patients with at least 6-month follow-up and baseline disease activity scores were enrolled ( = 353) and stratified into manifest CV disorder ("overt CVD"), any traditional CV risk factor ("atCVrisk") and no CV risk factor ("vlCVrisk") groups.